For wound care providers facing a skin substitute audit under Medicare, the regulatory ground has seismically shifted in numerous ways. On January 1, 2026, the Centers for Medicare & Medicaid Services (CMS) officially launched the Wasteful and Inappropriate Service Reduction (WISeR) Model. This initiative is not just another administrative hurdle; it is a technology-driven enforcement overhaul aimed directly at the wound care industry. With Medicare spending on skin substitutes (now referred to as Cellular, Acellular, and Matrix-Like Products or CAMPs) skyrocketing from $252 million to over $10 billion in just five years, CMS is deploying artificial intelligence (AI) to curb what it deems "wasteful" spending.

What is WISeR?

The WISeR model is a six-year pilot program currently active in six states: New Jersey, Ohio, Oklahoma, Texas, Arizona, and Washington. Unlike previous CMS initiatives, the "participants" in this model are not the healthcare providers, but rather specialized technology companies. These entities use AI and machine learning to review claims for medical necessity in real time. The crucial point for providers assessing what this means to their wound care practice: the model financially incentivizes technology companies to deny authorization.

The model targets high-cost services, with a primary focus on Cellular and/or Tissue-Based Products (CTPs) used in Hospital Outpatient Departments (HOPDs), Ambulatory Surgery Centers (ASCs), and physician offices. The goal is clear: by implementing a rigorous Prior Authorization (PA) framework, CMS intends to reduce skin substitute expenditures by nearly 90%. For providers in the six target states, this means every graft application is now under a microscope before a single dollar is paid.  

Consider Prior Authorization the New "Front-End" Audit

One way or another, providers in the states where the WISeR pilot is operating must prove themselves before they get paid for advanced wound care services, either through the prior authorization process or pre-payment medical reviews. Under the WISeR model, providers essentially have two choices, both of which carry significant legal and financial risk:

• Option A: Prior Authorization. Providers submit clinical documentation to a WISeR participant portal before treatment. The AI-driven system issues an "affirmation" or "non-affirmation."

• Option B: Pre-payment Medical Review. If a provider bypasses the PA process, the claim is automatically subject to a pre-payment audit. This means the MAC will withhold payment until a manual, granular review of the medical record is completed—a process that can devastate a clinic’s cash flow.

This "gatekeeper" system effectively turns the prior authorization process into a mandatory front-end audit. Unfortunately, even an affirmed PA does not provide a "safe harbor" from future retrospective audits by Unified Program Integrity Contractors (UPICs) or Recovery Audit Contractors (RACs). Because the technology companies managing these reviews are incentivized by the "savings" they generate, the likelihood of clinical documentation being flagged for "lack of medical necessity" or "improper sizing" is higher than ever. Documentation must now meticulously prove that conservative therapies were exhausted and that the wound trajectory justifies the continued use of high-cost biologicals.

Navigating the Minefield: How Health Law Alliance Protects Your Practice

The complexity of the WISeR model means that "business as usual" is a recipe for claim denials and reimbursement volatility. At Health Law Alliance, we specialize in healthcare regulatory defense, helping wound care providers stay ahead of CMS’s evolving AI tools.

Navigating the WISeR prior authorization portal requires more than just clinical skill—it requires a legal strategy. Our firm helps providers audit-proof their documentation to meet the exact standards required for PA affirmation. We assist in:

• Securing "Gold Card" Status: CMS has signaled that providers with a high track record of compliance may eventually be exempt from PA. We help you build the compliance infrastructure to achieve and maintain this status.

• Challenging Non-Affirmations: If your PA requests are being denied, our legal team can engage in peer-to-peer clinical reviews and formal appeals to ensure your patients receive care and your practice receives payment.

• Internal Compliance Audits: We conduct proactive "mock audits" to identify vulnerabilities in your HCPCS coding and documentation before a WISeR participant flags them.

The WISeR model has fundamentally changed the economics of wound care. In this new landscape, legal counsel is no longer a luxury—it is a business necessity. Health Law Alliance is dedicated to ensuring that your practice survives this era of unprecedented oversight, allowing you to focus on healing while we focus on your defense.